Mar 04 (Reuters) - Pulmonx Q4 revenue USD 22.598 million vs. IBES estimate USD 21.7 million.
Q4 gross profit USD 17.541 million
Q4 net income USD -10.425 million
Q4 income from operations USD -9.903 million
Q4 pretax profit USD -10.239 million
outlook FY revenue USD 90-92 million vs. IBES estimate USD 94.2 million
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments